New York – April 11, 2023- Research Nester’s recent market research report on “Conjunctivitis Treatment Market: Global Demand Analysis & Opportunity Outlook 2033” delivers a detailed competitors analysis and a detailed overview in terms of market segmentation by drug class, disease type, route of administration, end-user, and by region.

Growing Cases of Bacterial Conjunctivitis Infection to Promote Global Market Share of Conjunctivitis Treatment

The market’s expansion is estimated to grow majorly on account of the rising burden of infectious conjunctivitis. The rising incidence of bacterial conjunctivitis infection is expected to fuel the worldwide conjunctivitis treatment market in the approaching years.  Bacterial conjunctivitis can be transmitted from person to person in a variety of ways. These include transmission from mother to kid, hand-to-eye contact, and seeing or touching items that are contaminated. Bacteria can also spread by large droplets in the respiratory tract. Conjunctivitis can also be caused by mutations in the normal bacteria that live in the conjunctiva. Therefore, each case of conjunctivitis is expected to significantly contribute to the market.

Besides this, market growth is also expected on account of rising air pollution which can affect the eyes. Human eyes can be harmed by exposure to indoor or outdoor air pollution. Air pollution is responsible for 12% of all fatalities worldwide, and particulate matter 2.5 pollution causes allergic conjunctivitis and glaucoma. Eye diseases such as glaucoma, conjunctivitis, cataracts, and age-related macular degeneration can also be caused by other reasons, such as tobacco use, cooking, and inadequate indoor ventilation.

Some of the major growth factors and challenges that are associated with the growth of the global conjunctivitis treatment market are:

Growth Drivers:

• Rising levels of allergens and pollutants in the air
• Growing cases of bacterial eye infections

Challenges:

Drugs designed for treating conjunctivitis have adverse effects. In many cases, medication fails to match the sensitivity of the patient, which in turn causes severe effects, such as momentary burning, and stinging sensation in an infected eye. Moreover, after taking the drop or ointment, the side effects also compromised the vision. As a result, this factor is expected to stifle market growth over the forecast period. On the other hand, people suffering from eye infections try to treat it with home remedies and avoid visiting the hospitals. Moreover, there are strict regulations for the clinical trials and approvals of the new drugs.

Access our detailed report at: on “Conjunctivitis Treatment Market Analysis by Drug Class (Antibiotics, Antiviral, Antiallergic, Artificial Tears); Disease Type (Bacterial, Chemical, Viral, Allergic Conjunctivitis); Route of Administration (Oral, Topical); End-User (Hospitals, Online Pharmacies, Retail Pharmacies & Drug Stores) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033”@

https://www.researchnester.com/reports/conjunctivitis-treatment-market/4553

By drug class, the global conjunctivitis treatment market is segmented into antibiotics, antiviral, antiallergic, artificial tears, and others.  The antiallergic segment is to predicted to the highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period. The rising acceptance of antiallergic medications in allergic reactions, as these drugs enable faster healing and relief in such conditions, and the growing prevalence of allergies among people, particularly those who are prone to seasonal allergies, can be responsible for the segment's expansion. In the United States, for example, allergic conjunctivitis or allergic eye issues were seen in 40% of people in 2020.

The conjunctivitis treatment market in the North American region is expected to generate the highest revenue by the end of 2033. The market's expansion in the region is mostly ascribed to the rising prevalence of conjunctivitis, as well as the increasing use of corrective lenses by people in the region. According to estimates, almost 60% of persons aged 26-40 and 90% of people aged 70 wear corrective lenses in the United States. Corrective lenses are commonly used to cure hyperopia, astigmatism, myopia, and presbyopia. However, these lenses are used for curing hyperopia, astigmatism, myopia, and presbyopia, in some cases it also causes infection in the eye.

This report also provides the existing competitive scenario of some of the key players of the global conjunctivitis treatment market which includes company profiling of Novartis AG, Aurobindo Pharma Limited, Cipla Limited, Viatris Inc., Akorn Operating Company LLC, AbbVie Inc., Dr.Reddy’s Laboratories Limited, Micro Labs Limited, and Ocular Therapeutix, Inc.